Literature DB >> 16187833

Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain.

Lisa H Conti1, Jennifer E Costill, Sean Flynn, Jane E Tayler.   

Abstract

Male Wistar-Kyoto (WKY) and Brown Norway (BN) rats (11-12 weeks, n = 184) received an injection of saline, haloperidol, or clozapine, followed by an intracerebroventricular infusion of saline or corticotropin-releasing factor (CRF). Rats were tested for prepulse inhibition (PPI) of the acoustic startle response. BN rats showed less PPI than WKY rats, and neither antipsychotic alone enhanced PPI. In WKY rats, both haloperidol and clozapine attenuated the CRF-induced decrease in PPI. In CRF-treated BN rats, clozapine-enhanced PPI. A clozapine-induced decrease in startle amplitude was seen in CRF-treated BN rats but not in CRF-treated WKY rats. Although the disruption of PPI caused by exogenous CRF administration can be reversed by acute antipsychotic treatment, baseline PPI is not altered. (c) 2005 APA

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187833     DOI: 10.1037/0735-7044.119.4.1052

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  15 in total

1.  Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.

Authors:  Jane E Sutherland; Lisa H Conti
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

2.  Repeated norepinephrine receptor stimulation in the BNST induces sensorimotor gating deficits via corticotropin releasing factor.

Authors:  Abha Karki Rajbhandari; Vaishali P Bakshi
Journal:  Neuropharmacology       Date:  2020-04-29       Impact factor: 5.250

3.  PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-09-02       Impact factor: 4.530

4.  The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating.

Authors:  David Feifel; Paul D Shilling; Annabelle M Belcher
Journal:  Eur Neuropsychopharmacol       Date:  2011-10-01       Impact factor: 4.600

5.  The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

Authors:  Hugo A Tejeda; Vladimir I Chefer; Agustin Zapata; Toni S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

6.  The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.

Authors:  Jane E Sutherland; Linda C Burian; Jonathan Covault; Lisa H Conti
Journal:  Pharmacol Biochem Behav       Date:  2010-08-13       Impact factor: 3.533

7.  Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine.

Authors:  Cindy S Roegge; Charles Perraut; Xin Hao; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2007-02-22       Impact factor: 3.533

8.  Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.

Authors:  David Feifel; Paul D Shilling; Gilia Melendez
Journal:  Behav Neurosci       Date:  2011-04       Impact factor: 1.912

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

10.  The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats.

Authors:  Jane E Sutherland; Michelle E Page; Lisa H Conti
Journal:  Pharmacol Biochem Behav       Date:  2008-01-16       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.